CTS™ Essential 6™ Medium
CTS™ Essential 6™ Medium
Gibco™

CTS™ Essential 6™ Medium

CTS Essential 6 Medium is a cGMP-manufactured, xeno-free, feeder-free medium that supports the reprogramming of somatic cells and the spontaneous or directed differentiation of human pluripotent stem cells (PSCs).
製品番号(カタログ番号)数量
A4238501500 mL
製品番号(カタログ番号) A4238501
価格(JPY)
34,100
Each
お問い合わせください ›
数量:
500 mL

CTS Essential 6 Medium is a cGMP-manufactured, xeno-free, feeder-free medium that supports the reprogramming of somatic cells and the spontaneous or directed differentiation of human pluripotent stem cells (PSCs). The formulation is based on a medium originally developed by Guokai Chen, et al., in the laboratory of James Thomson (1). With only six essential components, CTS Essential 6 Medium helps minimize variability. To complete your PSC workflow with a matching culture medium for the growth and expansion of PSCs, use CTS Essential 8 Medium.

CTS Essential 6 Medium:

  • Provides a flexible format to suit different applications
  • Facilitates regulatory filings through cGMP manufacturing and the availability of documentation
  • Simplifies the transition from bench to clinic through the direct replacement of RUO Essential 6 Medium

Provides a flexible format

CTS Essential 6 Medium suits different applications and various cell types. It does not contain bFGF or TGFβ and can therefore support the formation of embryoid bodies. This medium can support the directed differentiation of various cell types and somatic cell reprogramming using a variety of methods.

Facilitates regulatory filings

CTS Essential 6 Medium is manufactured at a site that uses methods and controls that conform with cGMP for medical devices, 21 CFR Part 820. Our FDA-registered manufacturing site is ISO 13485-certified. Full documentation traceability and convenient access to our Drug Master File (DMF) are available for CTS Essential 6 Medium.

Simplifies transition from bench to clinic

CTS Essential 6 Medium contains the same six essential components as RUO Essential 6 Medium and, with its cGMP manufacturing process, this fully-defined formulation helps minimize variability. Like RUO Essential 6 Medium, CTS Essential 6 Medium does not contain bFGF or TGF-beta, which inhibit differentiation and negatively affect reprogramming efficiency, respectively. With its additional safety testing, including adventitious agents, CTS Essential 6 Medium enables a smooth transition from RUO Essential 6 Medium.

Commercialized in partnership with Cellular Dynamics International.

Reference

1. Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE, Wagner R, Lee GO, Antosiewicz-Bourget J, Teng JM, Thomson JA. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011 8(5):424-9.

細胞ベース、遺伝子ベース、または組織ベースの製品の研究での用途または製造。注意:ヒトまたは動物への直接投与は意図されていません。
仕様
使用対象(アプリケーション)Cell and Gene Therapy Research, Development, and Manufacturing
フォーマットBottle
製造品質ISO 13485, MDSAP, FDA-registered, 21 CFR 820
製品タイプCell Culture Medium
数量500 mL
品質保持期間12 months from date of manufacture
出荷条件Ambient
分類Xeno-free
形状Liquid
無菌性Sterile-filtered
Unit SizeEach
組成および保存条件
Store at 2–8°C and protect from light.

よくあるご質問(FAQ)

What is CTS?

The Gibco Cell Therapy Systems (CTS) portfolio of cell and gene therapy products are GMP manufactured, safety tested, and backed by regulatory documentation to support your transition from discovery through clinical and commercial manufacturing. Through our CTS solutions, we are committed to helping customers streamline therapeutic development, minimize risk, and ease the burden on their quality systems. Learn more here.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.